ArticleArchives of gynecology and obstetrics2025
Misdiagnosis in patients with obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome: a retrospective study of 164 cases.
Article in Archives of gynecology and obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Obstructed Hemivagina with Ipsilateral Renal Anomaly: Radiological Diagnosis, Outcome of Surgical Management and Literature Review.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- Late-onset OHVIRA syndrome in a 49-year-old woman with severe dysmenorrhea: a case report on vaginoscopic management.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe aim of this study was to summarize and analyze the incidence, underlying causes and related risk factors of misdiagnosis in patients with Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA) syndrome.
methodsThis is a single center, retrospective study conducted in a tertiary hospital, enrolling patients diagnosed with OHVIRA syndrome in our center between January 2000 and December 2023, with intact charts retrieved. We collected information related to misdiagnosis. The main outcome was the incidence of misdiagnosis in OHVIRA patients. Misdiagnosis related information, including the primary diagnosis and following management were displayed. We also analyzed the potential risk factors of misdiagnosis in OHVIRA patients by logistic regression.
resultsAmong 164 cases enrolled, 27 (16.5%) patients had experienced misdiagnosis. The most frequent primary misdiagnoses were pelvic abscess (8/27, 29.6%) and ovarian cyst (7/27, 25.9%). Complicating with pelvic endometriosis was the potential risk factor of misdiagnosis (OR 3.267, 95% CI 1.010-10.660). Presenting with irregular bleeding (OR 0.193, 95%CI 0.047-0.800) and performing pelvic MRI prior to diagnosis (OR 0.157, 95% CI 0.050-0.486) were potential protective factors for misdiagnosis in patients with OHVIRA syndrome.
conclusionMisdiagnosis is not uncommon in patients with OHVIRA syndrome. Alerting to related symptoms and optimizing various imaging modalities can effectively reduce the risk of misdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.